Individual patient data meta-analysis of 5 non-inferiority RCTs of reduced duration single agent adjuvant trastuzumab in the treatment of HER2 positive early breast cancer

被引:16
作者
Earl, H. M. [1 ]
Hiller, L. [2 ]
Dunn, J. A. [3 ]
Conte, P. F. [4 ]
D'Amico, R. [5 ]
Guarneri, V. [6 ]
Joensuu, H. [7 ]
Huttunen, T. [8 ]
Georgoulias, V. [9 ]
Abraham, J. [10 ]
Cameron, D. [11 ]
Miles, D. W. [12 ]
Wardley, A. M. [13 ]
Romieu, G. [14 ]
Debled, M. [15 ]
Faure-Mercier, C. [16 ]
Lindman, H. [17 ]
Fraser, J. [18 ]
Cox, D. [19 ]
Pivot, X. [20 ]
机构
[1] Cambridge Univ Hosp NHS Fdn Trust, Dept Oncol, Addenbrookes Hosp, NIHR Cambridge Biomed Res Ctr, Cambridge, England
[2] Univ Warwick, Warwick Clin Trials Unit, Coventry, England
[3] Univ Warwick, Warwick Clin Trials Unit, Coventry, England
[4] Univ Padua, Surg Oncol & Gastroenterol, Padua, Italy
[5] Univ Modena & Reggio Emilia, Dept Med & Surg Sci, Modena, Italy
[6] Dept Surg, Oncol & Gastroenterol Dept, Ist Oncol Veneto IRCCS, Padua, Italy
[7] Helsinki Univ Cent Hosp HUCH, Dept Oncol, Helsinki, Finland
[8] Management Estimates, Turku, Finland
[9] Univ Hosp Herakl, Med Oncol, Iraklion, Greece
[10] Cambridge Univ Hosp NHS Fdn Trust, Dept Oncol, Addenbrookes Hosp, Cambridge, England
[11] Western Gen Hosp, Oncol, Edinburgh Canc Ctr, Edinburgh, Scotland
[12] Mt Vernon Canc Ctr, Med Oncol, Northwood, England
[13] Outreach Res Innovat Grp Ltd, Manchester, England
[14] ICM Reg Canc Inst Montpellier, Med Oncol, Montpellier, France
[15] Inst Bergonie, Med Oncol, Bordeaux, France
[16] INCa Inst Natl Canc, Clin Res, Boulogne, France
[17] Univ Hosp Uppsala, Oncol, Akad Sjukhuset, Uppsala, Sweden
[18] BWSCC Beatson West Scotland Canc Ctr NHS Greater, Breast Team, Glasgow, Lanark, Scotland
[19] Ctr Leon Berard, Oncol, Lyon, France
[20] ICANS Inst Cancerol Strasbourg Europe, Med Oncol Dept, Strasbourg, France
关键词
D O I
10.1016/j.annonc.2021.08.2083
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LBA11
引用
收藏
页码:S1283 / S1283
页数:1
相关论文
empty
未找到相关数据